Found: 98
Select item for more details and to access through your institution.
Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 11, p. 3103, doi. 10.1007/s00520-013-1888-2
- By:
- Publication type:
- Article
Health‐related quality of life in transplant‐eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient‐reported outcomes from GRIFFIN.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1257, doi. 10.1002/ajh.27326
- By:
- Publication type:
- Article
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. E442, doi. 10.1002/ajh.24487
- By:
- Publication type:
- Article
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 3, p. 272, doi. 10.1002/ajh.22273
- By:
- Publication type:
- Article
Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 3, p. 201, doi. 10.1007/s40261-021-01012-x
- By:
- Publication type:
- Article
Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 5, p. 500, doi. 10.1111/ejh.13316
- By:
- Publication type:
- Article
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 6, p. 532, doi. 10.1111/ejh.12970
- By:
- Publication type:
- Article
Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 3, p. 263, doi. 10.1111/ejh.12826
- By:
- Publication type:
- Article
The Nephrologist as a Primary Care Provider for the Hemodialysis Patient.
- Published in:
- International Urology & Nephrology, 2005, v. 37, n. 1, p. 113, doi. 10.1007/s11255-004-0875-4
- By:
- Publication type:
- Article
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 411, doi. 10.1007/s40487-022-00198-0
- By:
- Publication type:
- Article
Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 659, doi. 10.1007/s40487-021-00175-z
- By:
- Publication type:
- Article
Use of Psychosocial Services Increases after a Social Worker–Mediated Intervention in Gynecology Oncology Patients.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Use of Psychosocial Services Increases after a Social Worker–Mediated Intervention in Gynecology Oncology Patients.
- Published in:
- Health & Social Work, 2013, v. 38, n. 2, p. 113, doi. 10.1093/hsw/hlt006
- By:
- Publication type:
- Article
Effectiveness of an Activity Tracker- and Internet-Based Adaptive Walking Program for Adults: A Randomized Controlled Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Collegial Phenomenon:The Social Mechanisms of Cooperation among Peers in a Corporate Law Partnership.
- Published in:
- 2003
- By:
- Publication type:
- Book Review
Unintentional drug overdose death trends in New Mexico, USA, 1990–2005: combinations of heroin, cocaine, prescription opioids and alcohol.
- Published in:
- Addiction, 2008, v. 103, n. 1, p. 126, doi. 10.1111/j.1360-0443.2007.02054.x
- By:
- Publication type:
- Article
Unintentional methadone-related overdose death in New Mexico (USA) and implications for surveillance, 1998–2002.
- Published in:
- Addiction, 2005, v. 100, n. 2, p. 176, doi. 10.1111/j.1360-0443.2004.00956.x
- By:
- Publication type:
- Article
P-180: Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in newly diagnosed Multiple Myeloma (NDMM): analysis of vascular thrombotic events (VTEs) in the GRIFFIN study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S135, doi. 10.1016/S2152-2650(21)02307-7
- By:
- Publication type:
- Article
P-132: Trial in progress: a mixed methods approach to understanding treatment experience of individuals receiving standard of care Isatuximab using patient reported, wearable, and digital health outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S107, doi. 10.1016/S2152-2650(21)02259-X
- By:
- Publication type:
- Article
OAB-027: Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T-cell therapy, for the treatment of patients with relapsed and refractory multiple myeloma (RRMM): updated results from KarMMa.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S17, doi. 10.1016/S2152-2650(21)02101-7
- By:
- Publication type:
- Article
Modified Hyper-CVAD With Proteasome Inhibition for Multiple Myeloma: A Single-Center Retrospective Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Daratumumab + Lenalidomide, Bortezomib & Dexamethasone Improves Depth of Response in Transplant-eligible Newly Diagnosed Multiple Myeloma: GRIFFIN.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e353, doi. 10.1016/j.clml.2019.09.583
- By:
- Publication type:
- Article
Prolonged Lenalidomide Maintenace Therapy Improves the Quality and Deep of Response in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e285, doi. 10.1016/j.clml.2019.09.470
- By:
- Publication type:
- Article
A single-center retrospective cohort analysis of venetoclax in relapsed/refractory multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e261, doi. 10.1016/j.clml.2019.09.432
- By:
- Publication type:
- Article
Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma After Frontline Transplant: A Multicenter, Randomized, Phase 3 Study (AURIGA).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e199, doi. 10.1016/j.clml.2019.09.332
- By:
- Publication type:
- Article
Clinical relevance of Minimal residual Disease assessment by NGS in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e179, doi. 10.1016/j.clml.2019.09.300
- By:
- Publication type:
- Article
Single cell Dissection of Resistance to anti-BCMA CAR-T cell Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e25, doi. 10.1016/j.clml.2019.09.038
- By:
- Publication type:
- Article
Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Single-Center Retrospective Cohort Analysis of Venetoclax in Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S339, doi. 10.1016/j.clml.2017.07.155
- By:
- Publication type:
- Article
Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e138, doi. 10.1016/j.clml.2017.03.250
- By:
- Publication type:
- Article
A Case Control Study of Syngeneic Transplantation Versus Autologous Transplantation for Multiple Myeloma: Two Decades of Experience at MD Anderson.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e8, doi. 10.1016/j.clml.2017.03.014
- By:
- Publication type:
- Article
Post Autologous Transplant (autoHCT)Therapies in High Risk MM. Subgroup analysis of Phase III BMTCTN 0702 STAMINA: autoHCT Followed by Lenalidomide Maintenance(Len)(AM) vs auto HCT and Len and Bortezomib (BZ) and Dexamethasone Consolidation Len Maintenance(ACM) vs Tandem autoHCT Len Maintenance
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e5, doi. 10.1016/j.clml.2017.03.009
- By:
- Publication type:
- Article
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspective.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Childhood Sexual Abuse and Age at Initiation of Injection Drug Use.
- Published in:
- American Journal of Public Health, 2005, v. 95, n. 4, p. 703, doi. 10.2105/AJPH.2003.019372
- By:
- Publication type:
- Article
Gender and international clinician educators.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinician-educators in emerging graduate medical education systems: description, roles and perceptions.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Do questions help? The impact of audience response systems on medical student learning: a randomised controlled trial.
- Published in:
- Postgraduate Medical Journal, 2015, v. 91, n. 1077, p. 361, doi. 10.1136/postgradmedj-2014-132987
- By:
- Publication type:
- Article
Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01088-6
- By:
- Publication type:
- Article
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01030-w
- By:
- Publication type:
- Article
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT).
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00624-6
- By:
- Publication type:
- Article
KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00507-2
- By:
- Publication type:
- Article
Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Mass Poisoning From Ethylene Glycol at a U.S. Military Base.
- Published in:
- Military Medicine, 2023, v. 188, n. 9/10, p. e3261, doi. 10.1093/milmed/usac380
- By:
- Publication type:
- Article
Optimization of a hydrophobic solid-phase extraction interface for matrix-assisted laser desorption/ionization.
- Published in:
- Journal of Mass Spectrometry, 1998, v. 33, n. 11, p. 1141, doi. 10.1002/(SICI)1096-9888(1998110)33:11<1141::AID-JMS732>3.0.CO;2-U
- By:
- Publication type:
- Article
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 6, p. 798, doi. 10.1111/bjh.12210
- By:
- Publication type:
- Article